PRKDC
Summary: This gene encodes the catalytic subunit of the DNA-dependent protein kinase (DNA-PK). It functions with the Ku70/Ku80 heterodimer protein in DNA double strand break repair and recombination. The protein encoded is a member of the PI3/PI4-kinase family.[provided by RefSeq, Jul 2010].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| protein kinase, DNA-activated, catalytic subunit | MIM:600899 | Ensembl:ENSG00000253729 | HGNC:HGNC:9413 | PA33776 | 8q11.21 |
GO terms in PRKDC
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IDA | GO:0003690 | double-stranded DNA binding |
| MF | HDA | GO:0003723 | RNA binding |
| MF | IDA | GO:0004672 | protein kinase activity |
| MF | IMP | GO:0004672 | protein kinase activity |
| MF | IDA | GO:0004674 | protein serine/threonine kinase activity |
| MF | TAS | GO:0004674 | protein serine/threonine kinase activity |
| MF | IDA | GO:0004677 | DNA-dependent protein kinase activity |
| MF | IPI | GO:0005515 | protein binding |
| MF | IEA | GO:0005524 | ATP binding |
| MF | IPI | GO:0008134 | transcription factor binding |
| MF | IBA | GO:0016301 | kinase activity |
| MF | IEA | GO:0019899 | enzyme binding |
| MF | IPI | GO:0019904 | protein domain specific binding |
| CC | HDA | GO:0000784 | nuclear chromosome, telomeric region |
| CC | IBA | GO:0005634 | nucleus |
| CC | IDA | GO:0005634 | nucleus |
| CC | IDA | GO:0005654 | nucleoplasm |
| CC | TAS | GO:0005654 | nucleoplasm |
| CC | IDA | GO:0005667 | transcription factor complex |
| CC | IDA | GO:0005730 | nucleolus |
| CC | TAS | GO:0005829 | cytosol |
| CC | IDA | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex |
| CC | HDA | GO:0016020 | membrane |
| CC | IMP | GO:0032991 | protein-containing complex |
| CC | IDA | GO:0032993 | protein-DNA complex |
| CC | IDA | GO:0070419 | nonhomologous end joining complex |
| BP | IEA | GO:0001756 | somitogenesis |
| BP | ISS | GO:0001933 | negative regulation of protein phosphorylation |
| BP | IDA | GO:0002218 | activation of innate immune response |
| BP | IEA | GO:0002326 | B cell lineage commitment |
| BP | IEA | GO:0002328 | pro-B cell differentiation |
| BP | IEA | GO:0002360 | T cell lineage commitment |
| BP | IEA | GO:0002638 | negative regulation of immunoglobulin production |
| BP | IBA | GO:0006281 | DNA repair |
| BP | IMP | GO:0006302 | double-strand break repair |
| BP | TAS | GO:0006303 | double-strand break repair via nonhomologous end joining |
| BP | TAS | GO:0006464 | cellular protein modification process |
| BP | IMP | GO:0006468 | protein phosphorylation |
| BP | IEA | GO:0007420 | brain development |
| BP | IEA | GO:0007507 | heart development |
| BP | IMP | GO:0008283 | cell proliferation |
| BP | IEA | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage |
| BP | IEA | GO:0010332 | response to gamma radiation |
| BP | IEA | GO:0014823 | response to activity |
| BP | IMP | GO:0016233 | telomere capping |
| BP | TAS | GO:0016567 | protein ubiquitination |
| BP | IDA | GO:0018105 | peptidyl-serine phosphorylation |
| BP | IEA | GO:0031648 | protein destabilization |
| BP | TAS | GO:0032481 | positive regulation of type I interferon production |
| BP | IMP | GO:0032869 | cellular response to insulin stimulus |
| BP | IEA | GO:0033077 | T cell differentiation in thymus |
| BP | IEA | GO:0033152 | immunoglobulin V(D)J recombination |
| BP | IEA | GO:0033153 | T cell receptor V(D)J recombination |
| BP | IEA | GO:0035234 | ectopic germ cell programmed cell death |
| BP | ISS | GO:0042752 | regulation of circadian rhythm |
| BP | IEA | GO:0043065 | positive regulation of apoptotic process |
| BP | IMP | GO:0043066 | negative regulation of apoptotic process |
| BP | IEA | GO:0045087 | innate immune response |
| BP | IMP | GO:0045944 | positive regulation of transcription by RNA polymerase II |
| BP | IEA | GO:0048146 | positive regulation of fibroblast proliferation |
| BP | IEA | GO:0048511 | rhythmic process |
| BP | IEA | GO:0048536 | spleen development |
| BP | IEA | GO:0048538 | thymus development |
| BP | IEA | GO:0048639 | positive regulation of developmental growth |
| BP | IMP | GO:0048660 | regulation of smooth muscle cell proliferation |
| BP | IMP | GO:0072431 | signal transduction involved in mitotic G1 DNA damage checkpoint |
| BP | TAS | GO:0097681 | double-strand break repair via alternative nonhomologous end joining |
| BP | IEA | GO:2000773 | negative regulation of cellular senescence |
| BP | IEA | GO:2001229 | negative regulation of response to gamma radiation |
Gene expression in normal tissue: PRKDC
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in PRKDC
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| reactome | R-HSA-168249 | Innate Immune System |
| reactome | R-HSA-168256 | Immune System |
| reactome | R-HSA-1834941 | STING mediated induction of host immune responses |
| reactome | R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA |
| reactome | R-HSA-3270619 | IRF3-mediated induction of type I IFN |
| reactome | R-HSA-392499 | Metabolism of proteins |
| reactome | R-HSA-5693532 | DNA Double-Strand Break Repair |
| reactome | R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) |
| reactome | R-HSA-597592 | Post-translational protein modification |
| reactome | R-HSA-73894 | DNA Repair |
| reactome | R-HSA-8852135 | Protein ubiquitination |
| reactome | R-HSA-8866654 | E3 ubiquitin ligases ubiquitinate target proteins |
| biocarta | faspathway | fas signaling pathway (cd95) |
| biocarta | g2pathway | cell cycle: g2/m checkpoint |
| biocarta | hivnefpathway | hiv-1 nef: negative effector of fas and tnf |
| kegg | hsa03450 | Non-homologous end-joining - Homo sapiens (human) |
| kegg | hsa04110 | Cell cycle - Homo sapiens (human) |
| pid | ar_pathway | Coregulation of Androgen receptor activity |
| pid | bard1pathway | BARD1 signaling events |
| pid | dnapk_pathway | DNA-PK pathway in nonhomologous end joining |
| pid | pi3kciaktpathway | Class I PI3K signaling events mediated by Akt |
| wikipathways | WP1530 | miRNA Regulation of DNA Damage Response |
| wikipathways | WP179 | Cell Cycle |
| wikipathways | WP2446 | Retinoblastoma (RB) in Cancer |
| wikipathways | WP314 | Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation |
| wikipathways | WP3651 | Pathways Affected in Adenoid Cystic Carcinoma |
| wikipathways | WP3878 | ATM Signaling Network in Development and Disease |
| wikipathways | WP438 | Non-homologous end joining |
| wikipathways | WP707 | DNA Damage Response |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD64 | Parbendazole | 1 |
| iGMDRD451 | Serdemetan | 4 |
| iGMDRD74 | Idarubicin | 3 |
| iGMDRD399 | Selumetinib | 3 |
| iGMDRD188 | Piperlongumine | 3 |
| iGMDRD398 | Sepantronium | 3 |
| iGMDRD780 | PP-30 | 1 |
| iGMDRD562 | Navitoclax | 3 |
| iGMDRD506 | Fedratinib | 5 |
| iGMDRD782 | DC-45-A2 | 4 |
| iGMDRD187 | BRD9876 | 2 |
| iGMDRD294 | Batimastat | 2 |
| iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 2 |
| iGMDRD138 | PX 12 | 3 |
| iGMDRD679 | Bistramide A | 2 |
| iGMDRD375 | GW-405833 | 2 |
| iGMDRD201 | SKI II | 3 |
| iGMDRD446 | LY 2183240 | 2 |
| iGMDRD61 | Kinetin riboside | 2 |
| iGMDRD779 | PRL-3 Inhibitor I | 1 |
| iGMDRD494 | Neopeltolide | 6 |
| iGMDRD126 | Tipifarnib | 3 |
| iGMDRD420 | Leucascandrolide A | 6 |
| iGMDRD300 | Tozasertib | 1 |
| iGMDRD886 | Compound 1541A | 2 |
| iGMDRD286 | Nsc 632839 | 5 |
| iGMDRD414 | MST-312 | 2 |
| iGMDRD158 | NSC141540 | 4 |
| iGMDRD202 | Curcumin | 3 |
| iGMDRD137 | Indisulam | 4 |
| iGMDRD103 | SN-38 | 1 |
| iGMDRD154 | NSC23766 | 4 |
| iGMDRD237 | ABT-751 | 2 |
| iGMDRD351 | GW843682X | 1 |
| iGMDRD314 | Tanespimycin | 3 |
| iGMDRD150 | RITA | 2 |
| iGMDRD560 | MK-2206 | 4 |
| iGMDRD405 | PIK-75 | 1 |
| iGMDRD84 | Lovastatin acid | 1 |
| iGMDRD512 | nutlin 3 | 1 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in PRKDC

